SNN

SNN

USD

Smith & Nephew SNATS Inc. Common Stock

$37.020+0.540 (1.480%)

Precio en Tiempo Real

Healthcare
Dispositivos médicos
Reino Unido

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$36.480

Máximo

$37.080

Mínimo

$36.460

Volumen

1.61M

Fundamentos de la Empresa

Capitalización de Mercado

15.8B

Industria

Dispositivos médicos

País

United Kingdom

Estadísticas de Negociación

Volumen Promedio

0.67M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $23.69Actual $37.020Máximo $38.79

Noticias Relacionadas

GlobeNewswire

Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices

Ver más
Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
GlobeNewswire

UFC® and Smith+Nephew announce multi-year extension of partnership

Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts organization, have

Ver más
UFC® and Smith+Nephew announce multi-year extension of partnership
Analyst Upgrades

Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target

Bernstein analyst Lisa Clive downgrades Smith & Nephew from Outperform to Market Perform and announces $37.5 price target.

Ver más
Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target
GlobeNewswire

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT)

Ver más
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.